Michael Schönhofen
Director/Board Member at FRESENIUS KABI ONCOLOGY LTD
Profile
Michael Schönhofen is currently working as a Non-Executive Director at Fresenius Kabi Oncology Ltd.
since 2010.
He is also currently serving as the President-Biopharma at Fresenius Kabi AG.
In terms of education, Dr. Schönhofen holds a doctorate degree from Technische Universität Darmstadt.
Michael Schönhofen active positions
| Companies | Position | Start |
|---|---|---|
| FRESENIUS KABI ONCOLOGY LTD | Director/Board Member | 2008-08-10 |
Fresenius Kabi AG
 Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Corporate Officer/Principal | - |
Training of Michael Schönhofen
| Technische Universität Darmstadt | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Fresenius Kabi Oncology Ltd.
 Fresenius Kabi Oncology Ltd. Miscellaneous Commercial ServicesCommercial Services Fresenius Kabi Oncology Ltd. is a research and development company, which engages in manufacturing and development of oncology drugs. It also develops active pharmaceutical ingredients, intermediates and oral and injectable finished dosage forms. The company was founded on March 18, 2003 and is headquartered in Gurgaon, India. | Commercial Services |
Fresenius Kabi AG
Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Health Technology |
- Stock Market
- Insiders
- Michael Schönhofen